CTOs on the Move

HealthMyne

www.healthmyne.com

 
The HealthMyne Quantitative Imaging Decision Support (QIDS)® software platform and its Rapid Precise Metrics (RPM)™ functionality transform multiple clinical decision support workflows by combining quantitative imaging metrics with relevant patient information.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

HealthMyne raised $15M on 08/01/2018

Similar Companies

Medco Center Of Campbellsville

Medco Center Of Campbellsville is a Campbellsville, KY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

BodyMedia

BodyMedia is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Pittsburgh, PA. To find more information about BodyMedia, please visit www.bodymedia.com

Haworth Cleaners

Haworth Cleaners is a Haworth, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

St Charles Parish Hospital

St Charles Parish Hospital is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Luling, LA. To find more information about St Charles Parish Hospital, please visit www.stch.net

Orbus Therapeutics

Orbus Therapeutics is dedicated to developing products that treat rare diseases for which there are few, if any, effective therapies. The company’s product candidate in development is eflornithine in an oral solution. Eflornithine is a novel cytostatic agent, which Orbus Therapeutics is developing for the treatment of patients with anaplastic glioma (AG), or Grade 3 glioma, a rare form of central nervous system cancer. Eflornithine irreversibly inhibits ornithine decarboxylase (ODC), a key enzyme in mammalian polyamine biosynthesis that is up-regulated in various types of cancer. Orbus Therapeutics intends to develop and commercialize eflornithine in North America.